ANIDO VICENTE JR 4
4 · AERIE PHARMACEUTICALS INC · Filed May 17, 2019
Insider Transaction Report
Form 4
ANIDO VICENTE JR
DirectorChief Executive Officer
Transactions
- Tax Payment
Common Stock
2019-05-16$40.54/sh−4,145$168,038→ 171,381 total - Award
Common Stock
2019-05-16+32,171→ 175,526 total
Footnotes (2)
- [F1]The reported transaction includes (i) 16,085 shares of common stock that vested on May 16, 2019 and (ii) 16,086 shares of common stock that will vest on May 16, 2020, subject to the reporting person's continued employment with the issuer through such date, pursuant to, in the case of each of clauses (i) and (ii), the issuer's compensation committee having determined that the requisite performance condition (the approval and launch of Rocklatan prior to September 30, 2019) has been achieved.
- [F2]Reflects shares of Common Stock withheld to satisfy tax withholding obligations in connection with the vesting of performance-based restricted Common Stock.